Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 USD | 0.00% | -4.36% | -11.75% |
Sales 2024 * | 206M 282M | Sales 2025 * | 243M 334M | Capitalization | 787M 1.08B |
---|---|---|---|---|---|
Net income 2024 * | 12M 16.46M | Net income 2025 * | 24M 32.93M | EV / Sales 2024 * | 3.56 x |
Net cash position 2024 * | 54.12M 74.25M | Net cash position 2025 * | 91.23M 125M | EV / Sales 2025 * | 2.86 x |
P/E ratio 2024 * |
113
x | P/E ratio 2025 * |
50.9
x | Employees | 1,102 |
Yield 2024 * |
0.06% | Yield 2025 * |
-
| Free-Float | 66.3% |
Latest transcript on Enfusion, Inc.
1 week | -4.36% | ||
Current month | -9.03% | ||
1 month | -5.41% | ||
3 months | +0.47% | ||
6 months | -11.11% | ||
Current year | -11.75% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 64 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +10.81% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 8.56 | 0.00% | 477,222 |
24-06-11 | 8.56 | -1.72% | 360,360 |
24-06-10 | 8.71 | +1.04% | 294,722 |
24-06-07 | 8.62 | -2.05% | 340,761 |
24-06-06 | 8.8 | -3.93% | 481,209 |
Delayed Quote Nyse, June 12, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.75% | 787M | |
+17.29% | 3,216B | |
+14.76% | 88.91B | |
+14.44% | 82.48B | |
+38.44% | 53.11B | |
-16.74% | 51.66B | |
+35.44% | 45.09B | |
-31.54% | 42.47B | |
+82.42% | 42.1B | |
-0.80% | 27.17B |
- Stock Market
- Equities
- ENFN Stock